Skip to main content

Together we are beating cancer

Donate now

Cancer News

Latest News

Showing 12 out of 6206 results
Eithne Costello

Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important. Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important.

by Phil Prime | Interview | 12 November 2021

12 November 2021

Lung cancer cells

Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected. Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected.

by Harry Jenkins | News | 11 November 2021

11 November 2021

Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials - we tell the story from discovery to translation. Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials - we tell the story from discovery to translation.

by Cancer Research UK | In depth | 5 November 2021

5 November 2021

We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment

by Phil Prime | Interview | 2 November 2021

2 November 2021

As the roof goes on our brand new Cancer Research UK Manchester Institute following a devastating fire in 2017, we hear from one of the PhD students who lived through it. As the roof goes on our brand new Cancer Research UK Manchester Institute following a devastating fire in 2017, we hear from one of the PhD students who lived through it.

by Emily Armstrong | In depth | 1 November 2021

1 November 2021

The Comprehensive Spending Review has set out the Government’s spending plans for the next three years - but what do these plans mean for our research community and its work? The Comprehensive Spending Review has set out the Government’s spending plans for the next three years - but what do these plans mean for our research community and its work?

by Oliver Buckley-Mellor | Analysis | 29 October 2021

29 October 2021

UK Parliament

The picture is still emerging and we don’t have a full sense yet of what each announcement will mean, but broadly it looks promising. Here’s what we know right now. The picture is still emerging and we don’t have a full sense yet of what each announcement will mean, but broadly it looks promising. Here’s what we know right now.

by Matt Sample | Analysis | 27 October 2021

27 October 2021

It’s completely up to you whether to go to cervical cancer screening. But the answers to these 6 questions could help you decide. It’s completely up to you whether to go to cervical cancer screening. But the answers to these 6 questions could help you decide.

by Rachel Orritt | Analysis | 25 October 2021

25 October 2021

Barrett's oesophagus under the microscope

Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now. Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now.

by Harry Jenkins | Analysis | 25 October 2021

25 October 2021